Related Experiment Video

Updated: Jun 1, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Effects of ethyl loflazepate on refractory epilepsy in children

Hideaki Kanemura1, Fumikazu Sano, Kanji Sugita

  • 1Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Journal of Child Neurology
|May 21, 2011
PubMed

Insights

Ethyl loflazepate demonstrated safety and efficacy in pediatric epilepsy. This treatment led to significant seizure reduction or freedom in a majority of young patients with refractory epilepsy.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Epilepsy is a common neurological disorder in children.
  • Refractory epilepsy in pediatric populations presents significant treatment challenges.
  • Limited therapeutic options exist for children with difficult-to-treat epilepsy.

Purpose of the Study:

  • To evaluate the safety and efficacy of ethyl loflazepate in children diagnosed with epilepsy.
  • To assess the impact of ethyl loflazepate on seizure frequency and control in pediatric patients.
  • To determine the potential of ethyl loflazepate as a treatment for refractory childhood epilepsy.

Main Methods:

  • A study involving 21 pediatric outpatients with epilepsy (generalized and localization-related) aged 9 months to 17 years.
  • Ethyl loflazepate administered at 0.015 mg/kg/day twice daily, with a mean final dose of 1.35 mg/day.
  • Treatment duration exceeded 24 months, with efficacy assessed based on seizure freedom and reduction.

Main Results:

  • Six children (28.6%) achieved complete seizure freedom for 6 months.
  • Eleven children (52.4%) experienced over 50% seizure reduction for more than 24 months.
  • High response rates observed in West syndrome (100%) and localization-related epilepsy (88.2%).
  • Adverse events were minimal, reported in only one patient.

Conclusions:

  • Ethyl loflazepate is a safe and effective treatment option for pediatric refractory epilepsy.
  • The drug significantly reduces seizure frequency and improves seizure control in children.
  • Ethyl loflazepate represents a valuable addition to the therapeutic arsenal for challenging pediatric epilepsy cases.

More Related Videos

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...